Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tema Healthcare AI ETF (NQ:HLTH)

27.78 -0.15 (-0.54%)
Streaming Delayed Price Updated: 1:24 PM EDT, Aug 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tema Healthcare AI ETF

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Longboard Pharmaceuticals, Inc. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Down 100 Points; US Manufacturing PMI Falls In December ↗
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ... 
Via Benzinga
Topics Stocks
News headline image
Cue Health: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket ↗
Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.7% to $0.0517 in... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Cue Health Reports Third Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Announce Third Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
Independent Clinical Study Confirms Cue Health’s COVID-19 Test Is As Accurate As a Lab Test
--News Direct-- 
Via News Direct
News headline image
Independent Clinical Study Confirms Cue Health's COVID-19 Test Is As Accurate As A Lab Test ↗
A new study published in Microbiology Spectrum put Cue Health’s (NASDAQ: HLTH) COVID 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Concerned Stockholders of Cue Health Send Letter to Board
From On behalf of Concerned Stockholders of Cue Health
Via Business Wire
News headline image
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
From Cue Health
Via Business Wire
News headline image
Cue Health Adopts Limited-Duration Shareholder Rights Plan
From Cue Health Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Cue Health to Present at Upcoming Investor Conferences
From Cue Health Inc.
Via Business Wire
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
--News Direct-- 
Via News Direct
News headline image
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test ↗
The healthcare technology company Cue Health Inc. (NASDAQ: HLTH) has become the first company to get De Novo authorization from the U.S. 
Via Benzinga
News headline image
Cue Health Reports Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Announce Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Cue Health’s Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
--News Direct-- 
Via News Direct
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.